Quantum Current Deferred Revenue from 2010 to 2026
| QNTM Stock | 7.60 0.59 8.42% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 900 K | Current Value 800 K | Quarterly Volatility 52.9 K |
Check Quantum BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quantum BioPharma's main balance sheet or income statement drivers, such as Selling General Administrative of 13.3 M, Other Operating Expenses of 19.3 M or Total Operating Expenses of 19.1 M, as well as many indicators such as Price To Sales Ratio of 5.5 K, Dividend Yield of 0.0 or PTB Ratio of 0.34. Quantum financial statements analysis is a perfect complement when working with Quantum BioPharma Valuation or Volatility modules.
Quantum | Current Deferred Revenue | Build AI portfolio with Quantum Stock |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Quantum BioPharma Correlation against competitors. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.